FDA Approved: XYWAV — Supplemental Application (Jazz Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for XYWAV, the calcium/magnesium/potassium/sodium oxybates formulation from Jazz Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Narcolepsy

Drugs mentioned

• XYWAV (CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES)

Snippet

SUPPL AP for XYWAV (CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES)